Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer-Reference-Cited by-同舟云学术

Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer

Published:2002-06 Issue:2 Volume:53 Page:316-327
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Martinez Alvaro A,Gustafson Gary,Gonzalez José,Armour Elwood,Mitchell Chris,Edmundson Gregory,Spencer William,Stromberg Jannifer,Huang Raywin,Vicini Frank

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference49 articles.

1. Status of radiation treatment of prostate cancer at Stanford University;Bagshaw;NCI Monogr,1988

2. Tumor control in definitive irradiation of localized carcinoma of the prostate;Perez;Int J Radiat Oncol Biol Phys,1986

3. A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States;Hanks;Int J Radiat Oncol Biol Phys,1987

4. Stage C adenocarcinoma of the prostate;Zagars;Cancer,1987

5. Radiotherapy for prostatic carcinoma;Leach;J Urol,1982

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes;Frontiers in Oncology;2023-11-23

2. The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments;Clinical Genitourinary Cancer;2022-02

3. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT;Medical Dosimetry;2022

4. Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the Prostate;International Journal of Radiation Oncology*Biology*Physics;2021-07

5. High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome;Cancer Reports;2021-06-23